Lv1
40 积分 2025-07-15 加入
High-Dose Methotrexate, Ibrutinib and Temozolomide (MIT) for the Treatment of Newly Diagnosed Primary Central Nervous System Lymphoma: A Multi-Center Prospective Phase II Study
11天前
已完结
Primary central nervous system lymphoma
11天前
已完结
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy
16天前
已完结
Efficacy and safety of the TEAM conditioning for autologous stem cell transplantation in lymphoma patients with high-risk of central nervous system relapse
2个月前
已完结
Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study
2个月前
已关闭
A Novel Prognostic Model for Primary CNS Lymphoma Incorporating Clinico-Laboratory Parameters
2个月前
已完结
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study
3个月前
已完结
Molecular and clinical diversity in primary central nervous system lymphoma
5个月前
已完结
Challenges in the Treatment of Newly Diagnosed and Recurrent Primary Central Nervous System Lymphoma
5个月前
已完结
A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma
5个月前
已完结
皖公网安备34019202002308
